Skip to content
Dx

ICD-10-CM 2027

ICD-10 code for polyneuropathy

G62.9

Polyneuropathy, unspecified

✓ Billable / specific

From the official ICD-10-CM alphabetic index entry “Polyneuropathy (peripheral)”. Page updated September 29, 2026.

About coding polyneuropathy

The ICD-10-CM code for polyneuropathy is G62.9 (Polyneuropathy, unspecified). The official index lists 77 more specific codes, so check the documentation for details such as type, cause, site or severity before settling on G62.9.

Within G62, choose G62.9 (Polyneuropathy, unspecified) only when documentation doesn't support a more specific option: drug-induced polyneuropathy (G62.0), alcoholic polyneuropathy (G62.1), polyneuropathy due to other toxic agents (G62.2) and other specified polyneuropathies (G62.8).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 073 (Cranial and Peripheral Nerve Disorders with MCC, relative weight 1.5779) and DRG 074 (Cranial and Peripheral Nerve Disorders without MCC, relative weight 1.0173), in MDC 01 (Diseases and Disorders of the Nervous System), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

More specific polyneuropathy codes (official index)

  • alcoholic G62.1 — Alcoholic polyneuropathy
  • amyloid (Portuguese) E85.1 — Neuropathic heredofamilial amyloidosis
  • transthyretin-related (ATTR) familial E85.1 — Neuropathic heredofamilial amyloidosis
  • arsenical G62.2 — Polyneuropathy due to other toxic agents
  • critical illness G62.81 — Critical illness polyneuropathy
  • demyelinating, chronic inflammatory (CIDP) G61.81 — Chronic inflammatory demyelinating polyneuritis
  • diabetic
  • drug-induced G62.0 — Drug-induced polyneuropathy
  • hereditary G60.9 — Hereditary and idiopathic neuropathy, unspecified
  • specified NEC G60.8 — Other hereditary and idiopathic neuropathies
  • idiopathic G60.9 — Hereditary and idiopathic neuropathy, unspecified
  • progressive G60.3 — Idiopathic progressive neuropathy
  • in (due to)
  • alcohol G62.1 — Alcoholic polyneuropathy
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • amyloidosis, familial (Portuguese) E85.1 — Neuropathic heredofamilial amyloidosis
  • antitetanus serum G61.1 — Serum neuropathy
  • arsenic G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • avitaminosis NEC E56.9 — Vitamin deficiency, unspecified
  • beriberi E51.11 — Dry beriberi
  • collagen vascular disease NEC M35.9 — Systemic involvement of connective tissue, unspecified
  • deficiency (of)
  • B (-complex) vitamins E53.9 — Vitamin B deficiency, unspecified
  • vitamin B6 E53.1 — Pyridoxine deficiency
  • diabetes
  • diphtheria A36.83 — Diphtheritic polyneuritis
  • drug or medicament G62.0 — Drug-induced polyneuropathy
  • correct substance properly administered
  • overdose or wrong substance given or taken
  • endocrine disease NEC E34.9 — Endocrine disorder, unspecified
  • herpes zoster B02.23 — Postherpetic polyneuropathy
  • hypoglycemia E16.2 — Hypoglycemia, unspecified
  • infectious
  • disease NEC B99 — Other and unspecified infectious diseases
  • mononucleosis B27.91 — Infectious mononucleosis, unspecified with polyneuropathy
  • lack of vitamin NEC E56.9 — Vitamin deficiency, unspecified
  • lead G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • leprosy A30.9 — Leprosy, unspecified
  • Lyme disease A69.22 — Other neurologic disorders in Lyme disease
  • metabolic disease NEC E88.9 — Metabolic disorder, unspecified
  • microscopic polyangiitis M31.7 — Microscopic polyangiitis
  • mumps B26.84 — Mumps polyneuropathy
  • neoplastic disease D49.9 — Neoplasm of unspecified behavior of unspecified site
  • nutritional deficiency NEC E63.9 — Nutritional deficiency, unspecified
  • organophosphate compounds G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • parasitic disease NEC B89 — Unspecified parasitic disease
  • pellagra E52 — Niacin deficiency [pellagra]
  • polyarteritis nodosa M30.0 — Polyarteritis nodosa
  • porphyria E80.20 — Unspecified porphyria
  • radiation G62.82 — Radiation-induced polyneuropathy
  • rheumatoid arthritis
  • sarcoidosis D86.89 — Sarcoidosis of other sites
  • serum G61.1 — Serum neuropathy
  • syphilis (late) A52.15 — Late syphilitic neuropathy
  • congenital A50.43 — Late congenital syphilitic polyneuropathy
  • systemic
  • connective tissue disorder M35.9 — Systemic involvement of connective tissue, unspecified
  • lupus erythematosus M32.19 — Other organ or system involvement in systemic lupus erythematosus
  • toxic agent NEC G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • transthyretin-related (ATTR) familial amyloid E85.1 — Neuropathic heredofamilial amyloidosis
  • triorthocresyl phosphate G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • tuberculosis A17.89 — Other tuberculosis of nervous system
  • uremia N18.9 — Chronic kidney disease, unspecified
  • vitamin B12 deficiency E53.8 — Deficiency of other specified B group vitamins
  • with anemia (pernicious) D51.0 — Vitamin B12 deficiency anemia due to intrinsic factor deficiency
  • due to dietary deficiency D51.3 — Other dietary vitamin B12 deficiency anemia
  • zoster B02.23 — Postherpetic polyneuropathy
  • inflammatory G61.9 — Inflammatory polyneuropathy, unspecified
  • chronic demyelinating (CIDP) G61.81 — Chronic inflammatory demyelinating polyneuritis
  • sequelae G65.1 — Sequelae of other inflammatory polyneuropathy
  • specified NEC G61.89 — Other inflammatory polyneuropathies
  • lead G62.2 — Polyneuropathy due to other toxic agents
  • sequelae G65.2 — Sequelae of toxic polyneuropathy
  • nutritional NEC E63.9 — Nutritional deficiency, unspecified
  • postherpetic (zoster) B02.23 — Postherpetic polyneuropathy
  • progressive G60.3 — Idiopathic progressive neuropathy
  • radiation-induced G62.82 — Radiation-induced polyneuropathy
  • sensory (hereditary) (idiopathic) G60.8 — Other hereditary and idiopathic neuropathies
  • specified NEC G62.89 — Other specified polyneuropathies
  • syphilitic (late) A52.15 — Late syphilitic neuropathy
  • congenital A50.43 — Late congenital syphilitic polyneuropathy

Common questions about polyneuropathy ICD-10 codes

What is the ICD-10 code for polyneuropathy?

G62.9 — Polyneuropathy, unspecified. More specific codes apply when the documentation supports them: G62.1, E85.1, E85.1, G62.2 and others below.

What is the ICD-10 code for alcoholic polyneuropathy?

G62.1 — Alcoholic polyneuropathy.

What is the ICD-10 code for amyloid polyneuropathy?

E85.1 — Neuropathic heredofamilial amyloidosis.

What is the ICD-10 code for arsenical polyneuropathy?

G62.2 — Polyneuropathy due to other toxic agents.

What is the ICD-10 code for critical illness polyneuropathy?

G62.81 — Critical illness polyneuropathy.

What is the ICD-10 code for drug-induced polyneuropathy?

G62.0 — Drug-induced polyneuropathy.

What is the ICD-10 code for hereditary polyneuropathy?

G60.9 — Hereditary and idiopathic neuropathy, unspecified.

Is G62.9 billable?

Yes. G62.9 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can G62.9 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict G62.9 as a principal diagnosis.

Is G62.9 a CC or MCC?

No. G62.9 is neither a CC nor an MCC under MS-DRG v44.0.